NasdaqGM:STAAMedical Equipment
Is STAAR Surgical (STAA) Undervalued After Naming A New CEO?
STAAR Surgical (STAA) has drawn investor attention after appointing Warren Foust as Chief Executive Officer and to its Board of Directors on 4 August 2026, following an extensive global search.
See our latest analysis for STAAR Surgical.
The CEO appointment comes after a stretch where STAAR Surgical’s 30 day share price return declined 11.78% and the 1 year total shareholder return fell 10.33%, while the 5 year total shareholder return was down 82.55%. This points to fading long term momentum...